EP2964638
Kínasólínhemlar örvandi stökkbrigðaforma viðtaka vaxtarþáttar þekjufrumna
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
5.3.2014EP published:
9.8.2017EP application number:
14710620.7
EP translation filed:
23.8.2017Grant published:
15.9.2017EPO information:
European Patent Register
Max expiry date:
4.3.2034Expiry date:
4.3.2027Next due date:
31.3.2027
Title:
QUINAZOLINE INHIBITORS OF ACTIVATING MUTANT FORMS OF EPIDERMAL GROWTH FACTOR RECEPTOR
Timeline
Today
5.3.2014EP application
9.8.2017EP Publication
23.8.2017Translation submitted
15.9.2017Registration published
4.3.2027Expires
Owner
Name:
Astrazeneca ABAddress:
151 85 Södertälje, SE
Inventor
Name:
LI, David, YunzhiAddress:
Shanghai, CN
Name:
WANG, JiabingAddress:
Shanghai, CN
Name:
YANG, ZhenfanAddress:
Shanghai, CN
Name:
ZENG, QingbeiAddress:
Shanghai, CN
Name:
ZHANG, XiaolinAddress:
Shanghai, CN
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
PCT/CN2013/072250Date:
6.3.2013Country:
WO
Classification
Categories:
C07D 403/12, A61K 31/495, A61K 31/505
Annual fees
Number
Paid
Expires
Payer
Number: 5
Paid: 8.2.2018
Expires: 4.3.2019
Payer: Árnason Faktor
Number: 6
Paid: 7.2.2019
Expires: 4.3.2020
Payer: Árnason Faktor
Number: 7
Paid: 18.2.2020
Expires: 4.3.2021
Payer: Árnason Faktor ehf.
Number: 8
Paid: 8.2.2021
Expires: 4.3.2022
Payer: Árnason Faktor ehf.
Number: 9
Paid: 8.2.2022
Expires: 4.3.2023
Payer: Árnason Faktor ehf.
Number: 10
Paid: 8.2.2023
Expires: 4.3.2024
Payer: Árnason Faktor ehf.
Number: 11
Paid: 12.2.2024
Expires: 4.3.2025
Payer: Árnason Faktor ehf.
Number: 12
Paid: 7.2.2025
Expires: 4.3.2026
Payer: Árnason Faktor ehf.
Number: 13
Paid: 5.3.2026
Expires: 4.3.2027
Payer: Árnason Faktor ehf.